Impact Biomedical revenue was $35.00k for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was $3.0k, down 57.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IBO annual revenue was $32.0k, with Infinity% growth year-over-year.
IBO past revenue growth
How has IBO's revenue growth performed historically?
On Aug 13, 2026, Impact Biomedical (NYSEMKT: IBO) reported Q2 2026 revenue of $3.00 thousand up 57.14% year over year. In the same quarter last year, Impact Biomedical's revenue was $7.00 thousand.
What was Impact Biomedical's revenue in 2025?
Impact Biomedical's annual revenue for the twelve months ending Dec 31, 2025 was $32.00 thousand, a Infinity% increase year over year.
How much does Impact Biomedical make in a day?
Based on Impact Biomedical annual revenue for the past three years, IBO makes an average of $29.22 per day.
What was Impact Biomedical's annual revenue growth in the past year?
As of Q3 2026, Impact Biomedical's revenue has grown 400% year over year. This is 140.25 percentage points higher than the US Biotechnology industry revenue growth rate of 259.75%. Impact Biomedical's revenue in the past year totaled $35.00 thousand.
How much does Impact Biomedical make in a year?
Impact Biomedical's revenue by year for the past three years is:
Impact Biomedical's revenue for the twelve months ending Dec 31, 2025 was $32.00 thousand, a Infinity% increase year over year.
Impact Biomedical's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
Impact Biomedical's annual revenue for 2023 was $0.00, a 100% decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.